Breaking News Instant updates and real-time market news.

EDIT

Editas Medicine

$71.66 /

-4.42 (-5.81%)

16:06
01/19/21
01/19
16:06
01/19/21
16:06

Editas Medicine files to sell 3.5M shares common stock

J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering. Cowen and Credit Suisse are acting as book-runners.

  • 24

    Jun

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

01/19/21 Morgan Stanley
Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley
01/13/21 Wells Fargo
Editas Medicine price target raised to $86 from $69 at Wells Fargo
01/08/21 Raymond James
Editas downgraded to Market Perform at Raymond James (Thursday morning)
01/07/21 Raymond James
Editas Medicine downgraded to Market Perform from Outperform at Raymond James

TODAY'S FREE FLY STORIES

Upgrade
TrueCar upgraded to Buy on accelerated improvement outlook at Benchmark » 06:27
02/25/21
02/25
06:27
02/25/21
06:27
TRUE

TrueCar

$5.07 /

+0.07 (+1.40%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

06:19 Today Benchmark
TrueCar upgraded to Buy from Hold at Benchmark
01/25/21 Goldman Sachs
TrueCar reinstated with a Neutral at Goldman Sachs
11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
11/11/20 Truist
TrueCar price target lowered to $4.50 from $6 at Truist
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

Downgrade
Norfolk Southern downgraded to In Line from Outperform at Evercore ISI » 06:26
02/25/21
02/25
06:26
02/25/21
06:26
NSC

Norfolk Southern

/

+

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
/

+

NSC Norfolk Southern
/

+

02/01/21 Argus
Norfolk Southern price target raised to $275 from $225 at Argus
01/28/21 Credit Suisse
Norfolk Southern price target lowered to $271 from $283 at Credit Suisse
01/28/21 RBC Capital
Norfolk Southern price target raised to $234 from $220 at RBC Capital
01/20/21 Susquehanna
Railroad recovery expected to continue in 2021, says Susquehanna
NSC Norfolk Southern
/

+

NSC Norfolk Southern
/

+

NSC Norfolk Southern
/

+

Recommendations
Coherus Biosciences price target lowered to $27 from $30 at Citi » 06:26
02/25/21
02/25
06:26
02/25/21
06:26
CHRS

Coherus Biosciences

$16.30 /

+0.1 (+0.62%)

Citi analyst Mohit Bansal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

06:16 Today H.C. Wainwright
Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright
11/19/20 Mizuho
Coherus Biosciences price target lowered to $30 from $35 at Mizuho
08/21/20 Mizuho
Express Scripts exclusion does not impact Coherus, says Mizuho
08/07/20 H.C. Wainwright
Coherus Biosciences price target raised to $33 from $30 at H.C. Wainwright
CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

Downgrade
Canadian Pacific downgraded to In Line from Outperform at Evercore ISI » 06:26
02/25/21
02/25
06:26
02/25/21
06:26
CP

Canadian Pacific

/

+

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
/

+

CP Canadian Pacific
/

+

02/04/21 Argus
Canadian Pacific price target raised to $390 from $350 at Argus
01/28/21 CIBC
Canadian Pacific price target lowered to C$490 from C$500 at CIBC
01/28/21 RBC Capital
Canadian Pacific price target raised to C$509 from C$506 at RBC Capital
01/28/21 TD Securities
Canadian Pacific price target raised to C$505 from C$500 at TD Securities
CP Canadian Pacific
/

+

Upgrade
Canadian National upgraded to Outperform from In Line at Evercore ISI » 06:26
02/25/21
02/25
06:26
02/25/21
06:26
CNI

Canadian National

$110.76 /

+1.885 (+1.73%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$110.76 /

+1.885 (+1.73%)

CNI Canadian National
$110.76 /

+1.885 (+1.73%)

01/28/21 Desjardins
Canadian National price target lowered to C$146 from C$150 at Desjardins
01/27/21 CIBC
Canadian National price target lowered to C$142 from C$153 at CIBC
01/27/21 BMO Capital
Canadian National price target lowered to C$150 from C$152 at BMO Capital
01/27/21 RBC Capital
Canadian National price target lowered to C$139 from C$155 at RBC Capital
CNI Canadian National
$110.76 /

+1.885 (+1.73%)

Earnings
Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 » 06:26
02/25/21
02/25
06:26
02/25/21
06:26
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Bayer has issued the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

02/10/21 Barclays
Bayer price target raised to EUR 55 from EUR 50 at Barclays
02/04/21
Citi opens positive 'Catalyst Watch' on Bayer
01/27/21 Deutsche Bank
Bayer price target raised to EUR 63 from EUR 62 at Deutsche Bank
01/20/21 Credit Suisse
Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Hot Stocks
AB InBev sees FY21 net CapEx $4.5B-$5B  06:25
02/25/21
02/25
06:25
02/25/21
06:25
BUD

AB InBev

$65.21 /

+0.17 (+0.26%)

 
ShowHide Related Items >><<
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

02/16/21 Truist
Truist downgrades Constellation Brands to Hold, sees Anheuser suit as overhang
02/02/21 Morgan Stanley
AB InBev ADR initiated with an Equal Weight at Morgan Stanley
01/22/21 HSBC
AB InBev price target raised to EUR 57 from EUR 56 at HSBC
01/21/21
Fly Intel: Top five analyst downgrades
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

Hot Stocks
AB InBev sees top, bottom line results in FY21 improving 'meaningfully' vs. FY20 » 06:25
02/25/21
02/25
06:25
02/25/21
06:25
BUD

AB InBev

$65.21 /

+0.17 (+0.26%)

The company said:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

02/16/21 Truist
Truist downgrades Constellation Brands to Hold, sees Anheuser suit as overhang
02/02/21 Morgan Stanley
AB InBev ADR initiated with an Equal Weight at Morgan Stanley
01/22/21 HSBC
AB InBev price target raised to EUR 57 from EUR 56 at HSBC
01/21/21
Fly Intel: Top five analyst downgrades
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

Hot Stocks
Novo Nordisk to invest DKK500M in Malov facility expansion » 06:25
02/25/21
02/25
06:25
02/25/21
06:25
NVO

Novo Nordisk

$72.22 /

+0.57 (+0.80%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$72.22 /

+0.57 (+0.80%)

NVO Novo Nordisk
$72.22 /

+0.57 (+0.80%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVO Novo Nordisk
$72.22 /

+0.57 (+0.80%)

NVO Novo Nordisk
$72.22 /

+0.57 (+0.80%)

NVO Novo Nordisk
$72.22 /

+0.57 (+0.80%)

Earnings
AB InBev reports Q4 normalized EPS $1.08, consensus 88c » 06:24
02/25/21
02/25
06:24
02/25/21
06:24
BUD

AB InBev

$65.21 /

+0.17 (+0.26%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

02/16/21 Truist
Truist downgrades Constellation Brands to Hold, sees Anheuser suit as overhang
02/02/21 Morgan Stanley
AB InBev ADR initiated with an Equal Weight at Morgan Stanley
01/22/21 HSBC
AB InBev price target raised to EUR 57 from EUR 56 at HSBC
01/21/21
Fly Intel: Top five analyst downgrades
BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

BUD AB InBev
$65.21 /

+0.17 (+0.26%)

Recommendations
Toll Brothers price target raised to $62 from $51 at Citi » 06:23
02/25/21
02/25
06:23
02/25/21
06:23
TOL

Toll Brothers

$55.98 /

+1.74 (+3.21%)

Citi analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

01/28/21 Wedbush
Toll Brothers downgraded to Neutral on valuation at Wedbush
01/28/21 Wedbush
Toll Brothers downgraded to Neutral from Outperform at Wedbush
12/08/20 UBS
NVR, Masco, LGI Homes, DR Horton, Fortune Brands top UBS picks in Building space
12/08/20 UBS
Toll Brothers initiated with a Buy at UBS
TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

Earnings
Acushnet Holdings reports Q4 EPS 29c, consensus 13c » 06:23
02/25/21
02/25
06:23
02/25/21
06:23
GOLF

Acushnet Holdings

$44.01 /

-0.605 (-1.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOLF Acushnet Holdings
$44.01 /

-0.605 (-1.36%)

10/30/20 Roth Capital
Roth upgrades Acushnet to Buy on 'universally positive' golf metrics
10/30/20 Roth Capital
Acushnet Holdings upgraded to Buy from Neutral at Roth Capital
06/29/20 SunTrust
Acushnet Holdings, Callaway Golf price targets raised at SunTrust
05/27/20 Roth Capital
Acushnet Holdings downgraded to Neutral at Roth Capital after strong run
GOLF Acushnet Holdings
$44.01 /

-0.605 (-1.36%)

Recommendations
Freshpet price target raised to $123 from $100 at Citi » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
FRPT

Freshpet

$154.68 /

+8.82 (+6.05%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

02/24/21 DA Davidson
Freshpet price target raised to $194 from $172 at DA Davidson
02/24/21 Credit Suisse
Freshpet price target raised to $150 from $115 at Credit Suisse
02/23/21 JPMorgan
Freshpet price target raised to $187 from $170 at JPMorgan
01/21/21 Oppenheimer
Oppenheimer upgrades 'uniquely positioned' Freshpet to Outperform
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

  • 24
    Feb
  • 27
    Feb
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

Earnings
Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Group sales amounted 10…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

02/10/21 Barclays
Bayer price target raised to EUR 55 from EUR 50 at Barclays
02/04/21
Citi opens positive 'Catalyst Watch' on Bayer
01/27/21 Deutsche Bank
Bayer price target raised to EUR 63 from EUR 62 at Deutsche Bank
01/20/21 Credit Suisse
Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Recommendations
Casper Sleep price target raised to $12 from $10 at Citi » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
CSPR

Casper Sleep

$9.17 /

-0.26 (-2.76%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

11/17/20
Fly Intel: Top five analyst downgrades
11/17/20 Morgan Stanley
Casper Sleep price target lowered to $6 from $8 at Morgan Stanley
11/17/20 Goldman Sachs
Casper Sleep downgraded to Neutral from Buy at Goldman Sachs
11/17/20 BofA
Casper Sleep downgraded to Underperform from Neutral at BofA
CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

Upgrade
Avangrid upgraded to Buy from Neutral at Janney Montgomery Scott » 06:21
02/25/21
02/25
06:21
02/25/21
06:21
AGR

Avangrid

$45.59 /

+0.39 (+0.86%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGR Avangrid
$45.59 /

+0.39 (+0.86%)

AGR Avangrid
$45.59 /

+0.39 (+0.86%)

10/26/20 UBS
PNM Resources downgraded to Neutral from Buy at UBS
10/22/20 Mizuho
PNM Resources downgraded to Neutral from Buy at Mizuho
10/21/20 Wells Fargo
PNM Resources downgraded to Equal Weight after Avangrid deal at Wells Fargo
10/15/20 Wells Fargo
Avangrid price target raised to $64 from $58 at Wells Fargo
AGR Avangrid
$45.59 /

+0.39 (+0.86%)

AGR Avangrid
$45.59 /

+0.39 (+0.86%)

Recommendations
Disney price target raised to $230 from $205 at Citi » 06:21
02/25/21
02/25
06:21
02/25/21
06:21
DIS

Disney

$197.52 /

+0.39 (+0.20%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
02/17/21 Argus
Disney price target raised to $225 from $200 at Argus
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/17/21 UBS
Disney price target raised to $215 from $200 at UBS
DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

Downgrade
Wex downgraded to Peer Perform from Outperform at Wolfe Research » 06:20
02/25/21
02/25
06:20
02/25/21
06:20
WEX

Wex

$230.23 /

+0.71 (+0.31%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WEX Wex
$230.23 /

+0.71 (+0.31%)

WEX Wex
$230.23 /

+0.71 (+0.31%)

02/11/21 Susquehanna
Wex price target raised to $250 from $210 at Susquehanna
01/29/21 Barclays
Wex price target raised to $246 from $165 at Barclays
01/25/21 Deutsche Bank
Wex price target raised to $240 from $172 at Deutsche Bank
01/06/21 Wolfe Research
Wex upgraded to Outperform from Peer Perform at Wolfe Research
WEX Wex
$230.23 /

+0.71 (+0.31%)

Periodicals
GameStop's Jim Bell forced to resign by the board, Business Insider reports » 06:20
02/25/21
02/25
06:20
02/25/21
06:20
GME

GameStop

$91.70 /

+46.67 (+103.64%)

GameStop's CFO Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

02/11/21 GLJ Research
GLJ calls end to Reddit-driven Tilray rally, predicts 100% share downside
02/01/21 Mizuho
Square benefited most from traders leaving Robinhood, says Mizuho
01/27/21 BofA
With GameStop shares trading at $213.50, BofA raises price target to $10
01/25/21 KeyBanc
Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc
GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

Recommendations
PPD price target raised to $42 from $40 at Citi » 06:19
02/25/21
02/25
06:19
02/25/21
06:19
PPD

PPD

$35.33 /

-1.035 (-2.85%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$35.33 /

-1.035 (-2.85%)

PPD PPD
$35.33 /

-1.035 (-2.85%)

10/29/20 Deutsche Bank
PPD price target raised to $38 from $33 at Deutsche Bank
10/12/20 Truist
PPD, Inc. initiated with a Buy at Truist
09/22/20 Mizuho
PPD, Inc. price target raised to $38 from $35 at Mizuho
09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
PPD PPD
$35.33 /

-1.035 (-2.85%)

  • 17
    Sep
PPD PPD
$35.33 /

-1.035 (-2.85%)

Upgrade
TrueCar upgraded to Buy from Hold at Benchmark » 06:19
02/25/21
02/25
06:19
02/25/21
06:19
TRUE

TrueCar

$5.07 /

+0.07 (+1.40%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

01/25/21 Goldman Sachs
TrueCar reinstated with a Neutral at Goldman Sachs
11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
11/11/20 Truist
TrueCar price target lowered to $4.50 from $6 at Truist
11/09/20
Fly Intel: Top five analyst upgrades
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

Downgrade
AT&T downgraded to Perform from Outperform at Oppenheimer » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
T

AT&T

$29.38 /

+0.21 (+0.72%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

02/08/21 Deutsche Bank
AT&T price target lowered to $31 from $36 at Deutsche Bank
01/27/21 MoffettNathanson
AT&T leverage 'too high for a shrinking company,' says MoffettNathanson
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

Recommendations
Flowserve price target raised to $44 from $42 at Citi » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
FLS

Flowserve

$38.67 /

-0.82 (-2.08%)

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

01/04/21 Credit Suisse
Flowserve downgraded to Neutral from Outperform at Credit Suisse
12/15/20
Fly Intel: Top five analyst upgrades
12/15/20 Stifel
Flowserve upgraded to Buy at Stifel ahead of expected multiple expansion
12/15/20 Stifel
Flowserve upgraded to Buy from Hold at Stifel
FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

Upgrade
ODP Corporation upgraded to Neutral from Sell at UBS » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
ODP

ODP Corporation

$41.40 /

-4.24 (-9.29%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

01/12/21 JPMorgan
ODP Corporation upgraded to Neutral following Staples bid at JPMorgan
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral from Underweight at JPMorgan
04/30/20 Sidoti
Office Depot initiated with a Buy at Sidoti
ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

Downgrade
Verizon downgraded to Perform from Outperform at Oppenheimer » 06:17
02/25/21
02/25
06:17
02/25/21
06:17
VZ

Verizon

/

+

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
/

+

VZ Verizon
/

+

01/27/21 KeyBanc
Dycom upgraded to Overweight at KeyBanc
01/26/21 MoffettNathanson
Verizon path to outperformance 'narrower' due to auction, says MoffettNathanson
01/26/21 JMP Securities
Synchrony price target raised to $43 from $36 at JMP Securities
12/02/20
Fly Intel: Top five analyst upgrades
VZ Verizon
/

+

VZ Verizon
/

+

VZ Verizon
/

+

VZ Verizon
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.